1 |
Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom AR, Heiss G, Lalouel JM, Higgins M, Rao DC. 1997. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. Ann Epidemiol 7: 13-21
DOI
ScienceOn
|
2 |
Schunkert H, Hense HW, Gimenez-Roqueplo AP, Stieber J, Keil U, Riegger GA, Jeunemaitre X. 1997. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 29: 628-633
DOI
ScienceOn
|
3 |
Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L. 1997. Polymorphisms of alpha-ADD1 and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357
DOI
ScienceOn
|
4 |
The National High Blood Pressure Education Program Coordinating Committee. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572
DOI
ScienceOn
|
5 |
Fornage M, Turner ST, Sing CF, Boerwinkle E. 1995. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 96: 295-300
|
6 |
International Obesity Task Force. 1999. Reassessment of anthropometric indices of obesity. Asian BMI/obesity workshop meeting, Milano, Italy
|
7 |
Klag MJ, Whelton PK, Randall BL Neaton JD, Brancaei FL, Stamler J. 1997. End-stage renal disease in African- American and white men. 16-year MRFIT findings. JAMA 277: 1293-1298
DOI
|
8 |
Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. 1995. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155:701-709
DOI
|
9 |
Korea National Statistical Office. 2006. The causes of death statistics in 2005
|
10 |
Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. 1994. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93: 1285-1287
DOI
ScienceOn
|
11 |
Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. 1995. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95: 948-953
DOI
ScienceOn
|
12 |
Iwai N, Shimoike H, Ohmichi N, Kinoshita M. 1995. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 25: 688-693
DOI
ScienceOn
|
13 |
Hegele RA, Brunt JH, Connelly PW. 1994. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 90: 2207- 2212
DOI
ScienceOn
|
14 |
Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, Ward R. 1994. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 24: 591-594
DOI
ScienceOn
|
15 |
Uemura K, Nakura J, Kohara K, Miki T. 2000. Association of ACE I/D polymorphism with cardiovascular risk factors. Hum Genet 107: 239-242
DOI
|
16 |
Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, Kroon AA. 2003. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study. J Hypertens 21: 81-86
DOI
ScienceOn
|
17 |
Stamler J. 1993. Dietary salt and blood pressure. Ann N Y Acad Sci 676: 122-156
DOI
|
18 |
Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D'Amico M, Buzzi L, Citterio L, Stella P, Rivera R, Bianchi G. 1998. Alpha-ADD1 polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 53: 1471-1478
DOI
ScienceOn
|
19 |
Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, Lombardi C, Soro A, Dettori F, Parpaglia PP, Alibrandi MT, Cusi D, Bianchi G. 1999. The role of alpha-ADD1 polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34: 649-654
DOI
|
20 |
Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams GH. 2002. Low-renin hypertension, altered sodium homeostasis, and an alpha-ADD1 polymorphism. Hypertension 39: 191-196
DOI
ScienceOn
|
21 |
Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA, Savolainen MJ. 1996. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 28: 1070-1075
DOI
ScienceOn
|
22 |
Forrester T, McFarlane-Anderson N, Bennet F, Wilks R, Puras A, Cooper R, Rotimi C, Durazo R, Tewksbury D, Morrison L. 1996. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 14: 315-321
DOI
|
23 |
Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ. 1996. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 28: 907-911
DOI
ScienceOn
|
24 |
O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. 1998. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766-1772
DOI
ScienceOn
|
25 |
Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. 1998. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97: 1773-1779
DOI
ScienceOn
|
26 |
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
DOI
ScienceOn
|
27 |
Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA, Savolainen MJ. 1996. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 28: 1070-1075
DOI
ScienceOn
|
28 |
Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, Wang J, Li Y, Bianchi G, Staessen JA, Liu L. 2004. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 22: 937-944
DOI
ScienceOn
|
29 |
Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. 2001 Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19: 1349-1358
DOI
ScienceOn
|
30 |
Yamagishi K, Iso H, Tanigawa T, Cui R, Kudo M, Shimamoto T. 2004. Alpha-ADD1 G460W polymorphism, urinary sodium excretion, and blood pressure in community-based samples. Am J Hypertens 17: 385-390
DOI
ScienceOn
|
31 |
Kim HJ, Paik HY, Lee SY, Shim JE, Kim YS. 2007. Salt usage behaviors are related to urinary sodium excretion in normotensive Korean adults. Asia Pac J Clin Nutr in press
|
32 |
Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. 1997. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 30: 1331-1337
DOI
ScienceOn
|
33 |
Berge KE, Berg K. 1998. Polymophism at the AGT and angiotensin II type 1 receptor loci and normal blood pressure. Clin Genet 53: 214-219
DOI
ScienceOn
|
34 |
Hall JE, Granger JP. 1982. Mechanism of the blood pressure and renal hemodynamic effects of captopril. Am J Cardiol 49: 1527-1529
DOI
ScienceOn
|
35 |
Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. 1992. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1: 72-75
DOI
ScienceOn
|
36 |
Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. 1997. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60: 1448-1460
DOI
ScienceOn
|
37 |
Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. 1999. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 17: 9-17
DOI
ScienceOn
|